Document Detail

Octreotide and low-fat breast milk in postoperative chylothorax.
MedLine Citation:
PMID:  15172311     Owner:  NLM     Status:  MEDLINE    
Chylothorax is a rare complication following cavo-pulmonary connection and can lead to significant morbidity in infants and young children. We report here the case of a 3-month-old infant who underwent bilateral cavo-pulmonary connections, and developed severe chylothorax refractory to the usual conservative and surgical treatments. His chylothorax resolved after using a combination of parenteral octreotide (Sandostatin, Novartis Pharmaceuticals, East Hanover, NJ) and low-fat breast milk.
Mohamed A Hamdan; Mary Lou Gaeta
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  77     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-06-02     Completed Date:  2004-06-29     Revised Date:  2006-11-02    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2215-7     Citation Subset:  AIM; IM    
Department of Pediatrics, King Abdulaziz Medical City, Al Ahsa, Saudi Arabia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chylothorax / drug therapy*,  etiology
Heart Bypass, Right / adverse effects*
Heart Defects, Congenital / surgery
Milk, Human*
Octreotide / administration & dosage*
Reg. No./Substance:
Comment In:
Ann Thorac Surg. 2005 Nov;80(5):1981-2; author reply 1982   [PMID:  16242514 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resection of primary pleural pedunculate hemangiopericytoma.
Next Document:  Chronic retained foreign bodies in the esophagus.